Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people ...
Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
Advances in genomics research and increasing adoption of high-throughput sequencing technologies are driving the demand for ...
The "RNA Sequencing Service Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions" has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results